rs6466587

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.196-999A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 152,040 control chromosomes in the GnomAD database, including 3,195 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 3195 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0140

Publications

12 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.196-999A>G intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2 Q03135-1Q2TNI1Q59E85
CAV1NM_001172895.1 linkc.103-999A>G intron_variant Intron 2 of 2 NP_001166366.1 A0A024R757Q2TNI1Q59E85
CAV1NM_001172896.2 linkc.103-999A>G intron_variant Intron 1 of 1 NP_001166367.1 A0A024R757Q2TNI1Q7Z4F3Q59E85
CAV1NM_001172897.2 linkc.103-999A>G intron_variant Intron 2 of 2 NP_001166368.1 A0A024R757Q2TNI1A9XTE5Q59E85

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.196-999A>G intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2 Q03135-1

Frequencies

GnomAD3 genomes
AF:
0.191
AC:
28948
AN:
151922
Hom.:
3192
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.236
Gnomad AMR
AF:
0.140
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.0100
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.0953
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.168
Gnomad OTH
AF:
0.199
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.191
AC:
28988
AN:
152040
Hom.:
3195
Cov.:
32
AF XY:
0.184
AC XY:
13652
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.295
AC:
12211
AN:
41438
American (AMR)
AF:
0.140
AC:
2136
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
739
AN:
3470
East Asian (EAS)
AF:
0.0101
AC:
52
AN:
5166
South Asian (SAS)
AF:
0.155
AC:
745
AN:
4814
European-Finnish (FIN)
AF:
0.0953
AC:
1008
AN:
10580
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.168
AC:
11402
AN:
67980
Other (OTH)
AF:
0.197
AC:
416
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1163
2327
3490
4654
5817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.176
Hom.:
4001
Bravo
AF:
0.198
Asia WGS
AF:
0.0880
AC:
311
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.0
DANN
Benign
0.51
PhyloP100
0.014
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6466587; hg19: chr7-116198001; API